Early-stage Life Science companies are crucial to the advancement of the healthcare and biotechnology sectors, but they typically operate on limited budgets, with lean teams and scarce resources. As a result, many fail to appreciate the need for an effective management liability insurance program, putting company assets and the personal assets of directors and officers at risk. Lockton Life Sciences is built to partner with clients and navigate the risk conversation with dedicated industry specialists and innovative solutions.
Download article (opens a new window)